Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Filings indexed 1,248 across all filing types
Latest filing 2018-10-20 Regulatory Filings
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 90% confidence The document is very short (539 characters) and contains addresses and stock exchange listing details for the National Stock Exchange of India and BSE Limited. There is no substantive financial data, report content, or detailed information. The presence of stock symbols and listing department addresses suggests this is likely a regulatory or listing-related announcement rather than a full report or detailed filing. Given the brevity and lack of report content, this fits best as a Regulatory Filing (RNS) which is a fallback category for miscellaneous filings that do not fit other categories.
2018-10-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015. It informs about the company's participation in an investor conference and meetings with analysts. The content is a brief announcement of investor relations activity without any financial data, detailed financial results, or report attachments. The document length is short (2222 characters), and it does not contain financial statements or detailed analysis. It is not a report itself but a regulatory announcement about investor meetings. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-10-08 English
Updates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the submission of a newspaper advertisement about the transfer of unclaimed interim dividends and corresponding equity shares to the Investor Education and Protection Fund (IEPF). It references regulatory compliance under SEBI Listing Obligations and Disclosure Requirements and the Companies Act, 2013, along with specific rules about unclaimed dividends and share transfers. The content is an announcement informing shareholders and the stock exchanges about this transfer process and the publication of related advertisements. It does not contain financial statements, detailed financial analysis, or management discussion. The document is relatively short (5970 characters) and serves as a regulatory announcement rather than a full report or detailed financial disclosure. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-09-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 100% confidence The document text is extremely short (65 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report content, or any announcement text. Given the lack of any meaningful information, this document cannot be classified as a full report or detailed filing. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous or non-informative filings.
2018-09-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice (964 characters) addressed to stock exchanges listing departments, providing a schedule of analyst and institutional investor meetings. It does not contain financial statements, detailed financial data, or regulatory certifications. It is not an announcement of voting results, management changes, or legal proceedings. It is also not a report or presentation but rather a notification of upcoming investor meetings. Given the short length and content, it does not fit into detailed report categories like Annual Report, Interim Report, or Earnings Release. It is best classified as a Regulatory Filing (RNS), which serves as a general category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-09-24 English
Updates
AGM Information Classification · 100% confidence The document is titled 'Proceedings of the 33rd Annual General Meeting for the financial year 2017-2018 held on August 24, 2018.' It details the attendance of directors and auditors, the agenda items discussed, voting procedures including e-voting and poll, and the resolutions passed such as adoption of financial statements, dividend declaration, reappointment of director, and ratification of auditors. The content is a summary of the AGM meeting proceedings rather than the full annual report or financial statements. It does not contain detailed financial data or management analysis but focuses on the meeting's conduct and decisions. Therefore, this document fits the category of AGM Information (AGM-R).
2018-09-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.